SOPH
SOPHiA GENETICS S.A.
NASDAQ · CHHealthcareMedical - Healthcare Information Services
$6.33+7.84%
Price as of Jul 20, 2026
SOPH growth
SOPHiA GENETICS S.A. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +20.9%
- EBITDA
- -39.1%
- EBIT
- -12.4%
- EPS
- -18.0%
- Free cash flow
- +2.6%
- Operating cash flow
- -8.2%
Forward estimates
- Revenue
- +18.9%
- EBITDA
- -39.6%
- EPS
- +31.1%
Three-year CAGR
- Revenue
- +17.6%
- EBITDA
- -26.9%
- EBIT
- -6.5%
- Net income
- -26.4%
- EPS
- -23.2%
- Free cash flow
- +24.3%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.